
IRB Consent Form Compliance Analyzer
Audit research consent forms for IRB compliance
What You Can Do
You submit your research consent form and receive a systematic compliance review against 45 CFR 46 and 21 CFR 56 regulations. The skill identifies specific deficiencies, maps each gap to regulatory requirements, and generates institution-specific remediation guidance with reference language you can use to bring your form into compliance.
Features
Automatically checks consent forms against both 45 CFR 46 (common rule for human subjects) and 21 CFR 56 (FDA regulations for investigational products). Identifies which regulations apply to your specific research and flags violations in each.
Highlights missing or inadequate disclosures including informed consent elements, risks, benefits, alternatives, confidentiality protections, contact information, voluntary participation language, and compensation terms. Each gap is prioritized by severity.
Generates remediation language tailored to your institution's research context, population, and study design. Recommendations include specific rewording rather than generic advice, so you can implement changes immediately.
Every finding includes the precise CFR citation and subsection, so your compliance team can verify regulatory requirements and update institutional templates. Full audit trail for documentation purposes.
Identifies when your research involves vulnerable subjects (minors, pregnant women, prisoners, cognitively impaired) and flags additional disclosure requirements specific to these populations under 45 CFR 46 Subpart B, C, or D.
Delivers findings in a structured format with executive summary, detailed deficiencies by regulatory section, remediation roadmap, and revision checklist. Format works directly with IRB submission systems.
Provides compliant template language for common elements (risk disclosure, privacy notice, emergency contact, withdrawal procedures) that meet regulatory standards and can be adapted to your specific study.
Example Output
Consent Form Compliance Review: Pediatric Asthma Study
Summary: 7 deficiencies identified (4 critical, 3 minor). Form requires revision before IRB approval.
Critical Findings:
-
Missing Risk Disclosure (45 CFR 46.116(a)(1)) — Current text: "standard clinical procedures." Required: Specify actual risks (e.g., "blood draws may cause bruising or infection"). Recommendation: Insert detailed risk section with incidence rates.
-
Inadequate Benefit Disclosure (45 CFR 46.116(a)(2)) — Does not distinguish between direct benefits to participant vs. knowledge benefits to science. Revision: Add two separate paragraphs explaining each.
-
Minor Subjects - Missing Parental Consent (45 CFR 46.408) — Form states "participant consent" but lacks separate parental permission document. Action: Generate parental permission form using 45 CFR 46.408 template language.
Recommended Revision Language: "Risks of this study include: (1) Brief discomfort during blood draws (~5 min), occurring in 100% of participants; (2) Possible bruising at needle site, occurring in ~2% of participants..."
Next Steps: Submit revised form to IRB with change summary referencing 45 CFR 46 sections above.
What's Included
- Compliance Analysis Framework: Complete checklist covering all required elements under 45 CFR 46.116 (informed consent requirements) and 21 CFR 56.109 (FDA investigational new drug standards). Systematically evaluates each section of your form.
- Regulatory Reference Database: Built-in mapping of CFR citations to specific consent form elements. Every deficiency links to the exact regulation and subsection so your IRB coordinator can verify requirements and update institutional policies.
- Remediation Template Library: Customizable language templates for common disclosure sections: risk notification, benefit clarification, privacy safeguards, compensation terms, voluntary withdrawal, emergency contacts, and investigator credentials. Meets regulatory standards.
- Special Population Protocols: Detection rules for vulnerable subjects (children, pregnant women, prisoners, mentally impaired, economically disadvantaged). Flags additional requirements under 45 CFR 46 Subparts B, C, D, and corresponding FDA requirements.
- Severity-Ranked Deficiency Report: Organizes findings by risk level (critical, major, minor) so your team prioritizes high-impact revisions. Each deficiency includes remediation priority, estimated effort to fix, and regulatory consequence of non-compliance.
- IRB Documentation Package: Structured output that works with electronic IRB submission systems (eIRB). Includes executive summary, detailed findings with citations, revision guidance, and change-tracking checklist for your institutional review.
Who It's For
- IRB Coordinators
- Research Compliance Officers
- Research Administrators
- Institutional Quality Assurance Managers
- Regulatory Affairs Specialists
Best For
- Pre-submission consent form audit before IRB review
- Institutional consent form template development and compliance verification
- Post-deficiency remediation guidance when IRB requests revisions
- FDA-regulated research (investigational drugs, devices, biologics) compliance verification
- Multi-institutional research coordination and regulatory gap closure







